Actinomycetes : The Antibiotics Producers

Beyond being the most important natural compound source, actinomycetes are the origin of up to two-thirds of all clinically used antibiotics. Currently, new antimicrobials are urgently needed, as infections caused by antibiotic-resistant pathogens are on the rise. In the identification of new antibi...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (362 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05344nam-a2201441z--4500
001 993546170504498
005 20231214133548.0
006 m o d
007 cr|mn|---annan
008 202105s2020 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000040898 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/69028 
035 |a (EXLCZ)995400000000040898 
041 0 |a eng 
100 1 |a Stegmann, Evi  |4 edt 
245 1 0 |a Actinomycetes  |b The Antibiotics Producers 
246 |a Actinomycetes 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (362 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 |a Open access  |f Unrestricted online access  |2 star 
520 |a Beyond being the most important natural compound source, actinomycetes are the origin of up to two-thirds of all clinically used antibiotics. Currently, new antimicrobials are urgently needed, as infections caused by antibiotic-resistant pathogens are on the rise. In the identification of new antibiotics, many scientists are currently investigating biosynthetic aspects of antibiotic production in actinomycetes. Since the emergence of next-generation sequencing technologies, the field of antibiotics research has experienced a remarkable revival. These bacteria have the potential to produce more antibiotics than previously thought possible. Some antibiotics are produced in standard media, while others require the presence of a specific signaling molecule in the medium. Others, however, are only produced when the native regulation of the biosynthesis gene cluster is overruled. This book covers topics in the field of antibiotic-producing actinomycetes. The following tops are addressed: - Approaches to access novel antibiotic producers for novel natural compounds - Omics and genome mining approaches for the discovery of novel natural compounds - Analyses and genetic engineering of antibiotic biosynthesis - Regulation of the secondary metabolism in actinomycetes 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Biology, life sciences  |2 bicssc 
653 |a Streptomyces 
653 |a biogeography 
653 |a comparative genomics 
653 |a diversification 
653 |a secondary metabolite biosynthetic gene clusters 
653 |a SMGC 
653 |a natural products 
653 |a streptomyces 
653 |a rishirilide 
653 |a biosynthesis 
653 |a polyketides 
653 |a polynucleotide phosphorylase 
653 |a ribonuclease 
653 |a regulation 
653 |a promoter 
653 |a RNA decay 
653 |a polyadenylation 
653 |a (p)ppGpp 
653 |a antibiotic 
653 |a antibiotics 
653 |a geomicrobiology 
653 |a Illumina sequencing 
653 |a microbiome diversity 
653 |a Actinobacteria 
653 |a Cave microbiology 
653 |a secondary metabolite 
653 |a rare Actinobacteria 
653 |a Amycolatopsis 
653 |a unculturability 
653 |a siderophore 
653 |a glycopeptide antibiotics 
653 |a dbv cluster 
653 |a regulatory genes 
653 |a StrR 
653 |a LAL 
653 |a LuxR solo 
653 |a dalbavancin 
653 |a A40926 
653 |a Streptomyces lividans 
653 |a secretion pathways 
653 |a secretory proteins 
653 |a signal peptides 
653 |a actinomycetes 
653 |a teicoplanin 
653 |a van resistance genes 
653 |a Streptomyces tsukubaensis 
653 |a tacrolimus 
653 |a FK506 
653 |a omics 
653 |a screening 
653 |a secondary metabolism 
653 |a differentiation 
653 |a elicitors 
653 |a morphology 
653 |a liquid cultures 
653 |a metagenomics 
653 |a rare actinomycetes 
653 |a dereplication 
653 |a metabolomics 
653 |a genome mining 
653 |a secondary metabolites 
653 |a novel compounds 
653 |a physicochemical screening 
653 |a physical and chemical properties 
653 |a structural diversity 
653 |a biological activity 
653 |a Actinoallomurus 
653 |a antibiotics polyethers 
653 |a lysolipin 
653 |a minimal PKS II 
653 |a cyclases 
653 |a benz[a]naphthacene quinone 
653 |a tridecaketide 
653 |a aromatic polyketide 
653 |a pentacyclic angular polyphenol 
653 |a extended polyketide chain 
653 |a actinobacteria 
653 |a β-lactamase 
653 |a resistance 
653 |a β-lactamase inhibitor 
653 |a polyketide synthases 
653 |a acyltransferases 
653 |a engineering 
653 |a new bioactive compounds 
653 |a symbiosis 
653 |a drug discovery 
653 |a chemical ecology 
653 |a culture-based approaches 
653 |a strain 
653 |a specialized metabolites 
653 |a biosynthetic gene cluster 
776 |z 3-03936-910-5 
776 |z 3-03936-911-3 
700 1 |a Mast, Yvonne  |4 edt 
700 1 |a Stegmann, Evi  |4 oth 
700 1 |a Mast, Yvonne  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:57:45 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338153660004498&Force_direct=true  |Z 5338153660004498  |b Available  |8 5338153660004498